Levin Sedran & Berman Attorneys Appointed to Lead Xarelto Litigation

PHILADELPHIA, Feb. 11, 2015 /PRNewswire/ — Philadelphia attorneys Dianne M. Nast of NastLaw LLC, Frederick Longer of Levin, Fishbein, Sedran & Berman, and Dr. Mark Alan Hoffman of Ross Feller Casey LLP have been appointed to the Plaintiff’s Steering Committee in the litigation against Xarelto®, a widely prescribed blood thinning medication manufactured by Bayer and marketed by Janssen. Federal Judge Eldon E. Fallon of Louisiana made the Plaintiff’s Steering Committee (PSC) appointments.

Three Philadelphia attorneys were also appointed Plaintiff’s Co-Liaison Counsel to lead the Xarelto litigation in Pennsylvania. Michael M. Weinkowitz of Levin, Fishbein, Sedran & Berman, Daniel N. Gallucci of NastLaw, and Laura Feldman of Feldman & Pinto were appointed by Judge Arnold L. New, Philadelphia Court of Common Pleas.

See the full press release here.